In this study, we demonstrated that hepatic LeXis is negatively correlated with steatosis, and that patients with NASH have increased expression of plasma LeXis. In addition, plasma LeXis was independently associated with NASH with an acceptable diagnostic performance. Here, CT70 is linked to metabolic dysfunction-associated steatohepatitis.